PURPOSE: We determined if a high-intensity aerobic exercise program would be safe, improve expected fitness and clinical outcomes, and alter exploratory phosphorous magnetic resonance spectroscopy (31 P MRS) outcomes in persons with multiple sclerosis (PwMS). METHODS: This open-label prospective pilot study compared 2 cohorts of ambulatory PwMS matched for age, sex and VO 2 max. Cohorts underwent 8-weeks of high-intensity aerobic exercise (MS-Ex, n=10) or guided stretching (MS-Ctr, n=7). Aerobic exercise consisted of four 30-minute sessions per week while maintaining ≥70% maximal heart rate. Changes in cardiorespiratory fitness, clinical outcomes, and 31 P MRS of tibialis anterior muscle (TA) and brain were compared. Cross-sectional 31 P MRS comparisons were made between all MS participants and a separate matched healthy control (HC) population. RESULTS: The MS-Ex cohort achieved target increases in VO 2 max (mean +12.7%, p=<0.001, between-group improvement p=0.03). One participant was withdrawn for exercise-induced syncope. The MS-Ex cohort had within-group improvements in fat mass (−5.8%, p=0.04), lean muscle mass (+2.6%, p=0.02), Symbol Digit Modalities Test (+15.1%, p=0.04), and cognitive subscore of the Modified Fatigue Impact Scale (MFIS: −26%, p=0.03) while only the physical subscore of the MFIS improved in MS-Ctr (−16.1%, p=0.007). 31 P MRS revealed significant within-group increases in MS-Ex participants in TA rate-constant of PCr recovery (k PCr ; +31.5%, p=0.03) and ATP/PCr (+3.2%, p=0.01), and near significant between-group increases in TA k PCr (p=0.05) but no significant changes in brain 31 P MRS following exercise. Cross-sectional differences existed between MS and HC brain PCr/Pi (4.61 ± 0.44, 3.93 ± 0.19 p=0.0019).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.